Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DSLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DSLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DULDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DULDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DVLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DVLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DXLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DXLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DYLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DYLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9E1LDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9E1LDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DRLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DRLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9E0LDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9E0LDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DWLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DWLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
IPR2023-00480, No. 49 Other other - Petitioners Request for Oral Argument (P.T.A.B. May. 10, 2024)
Cite Document
IPR2023-00480, No. 49 Other other - Petitioners Request for Oral Argument (P.T.A.B. May. 10, 2024)
+ More Snippets
Document
IPR2023-00480, No. 58 Notice Updated Mandatory Notice - Patent Owners Update to Mandatory Notices (P.T.A.B. Jun. 28, 2024)
Cite Document
IPR2023-00480, No. 58 Notice Updated Mandatory Notice - Patent Owners Update to Mandatory Notices (P.T.A.B. Jun. 28, 2024)
+ More Snippets
Document
IPR2023-00480, No. 45 Notice Other - Notice of Joint Stipulation to Modify Due Date 3 (P.T.A.B. Apr. 15, 2024)
Cite Document
IPR2023-00480, No. 45 Notice Other - Notice of Joint Stipulation to Modify Due Date 3 (P.T.A.B. Apr. 15, 2024)
+ More Snippets
Document
IPR2023-00480, No. 44 Notice Updated Mandatory Notice - Patent Owners Updated Mandatory Notices (P.T.A.B. Apr. 12, 2024)
Cite Document
IPR2023-00480, No. 44 Notice Updated Mandatory Notice - Patent Owners Updated Mandatory Notices (P.T.A.B. Apr. 12, 2024)
+ More Snippets
Document
IPR2023-00480, No. 54 Motion Other - Petitioners Motion to Seal (P.T.A.B. Jun. 20, 2024)
Cite Document
IPR2023-00480, No. 54 Motion Other - Petitioners Motion to Seal (P.T.A.B. Jun. 20, 2024)
+ More Snippets
Document
IPR2023-00480, No. 55 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jun. 20, 2024)
Cite Document
IPR2023-00480, No. 55 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jun. 20, 2024)
+ More Snippets